https://www.celltree.co.kr/wp-content/uploads/2018/07/news-thumbnail.png484800셀트리/wp-content/uploads/2018/03/celltree-logo.png셀트리2019-10-22 13:58:292019-10-22 13:58:29메디포스트, 12월 美FDA 미팅추진…뉴모스템등 임상 속도
https://www.celltree.co.kr/wp-content/uploads/2019/06/gmp-img-1.jpg534800셀트리/wp-content/uploads/2018/03/celltree-logo.png셀트리2019-09-03 19:18:032019-09-04 14:18:45주사형 무릎골관절염치료제 임상 개시… 차세대 치료제 본격 개발
https://www.celltree.co.kr/wp-content/uploads/2019/08/img-pneumostem.jpg9001200셀트리/wp-content/uploads/2018/03/celltree-logo.png셀트리2019-08-23 11:35:472019-08-26 11:37:13뉴모스템® 美 FDA 패스트트랙 지정
https://www.celltree.co.kr/wp-content/uploads/2017/11/news-171108.jpg500800셀트리/wp-content/uploads/2018/03/celltree-logo.png셀트리2019-05-31 19:40:482019-06-03 19:45:12메디포스트, 바이오 USA서 임상 개발 성과 발표
https://www.celltree.co.kr/wp-content/uploads/2019/05/news-1905301.jpg600880셀트리/wp-content/uploads/2018/03/celltree-logo.png셀트리2019-05-30 15:20:262019-05-30 15:24:07메디포스트, ISCT 연례회의서 국내외 임상 경험 발표